| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-3659(98)00081-9 |
| P698 | PubMed publication ID | 9801437 |
| P2093 | author name string | Tabata Y | |
| Matsui Y | |||
| Ikada Y | |||
| P2860 | cites work | Immobilized metal ion affinity chromatography | Q72553180 |
| Preface | Q73850239 | ||
| Metal chelate affinity chromatography, a new approach to protein fractionation | Q33996883 | ||
| Bone regeneration by basic fibroblast growth factor complexed with biodegradable hydrogels | Q38551104 | ||
| Potential efficacy of basic fibroblast growth factor incorporated in biodegradable hydrogels for skull bone regeneration | Q38558321 | ||
| Biodegradable Polymers for Protein and Peptide Drug Delivery | Q38574913 | ||
| In vitro evaluation of cytotoxicity of diepoxy compounds used for biomaterial modification | Q41331334 | ||
| Single step purification of biologically active recombinant rat basic fibroblast growth factor by immobilized metal affinity chromatography | Q46123717 | ||
| Release of human serum albumin from poly(lactide-co-glycolide) microspheres | Q46854396 | ||
| Complexation of basic fibroblast growth factor with gelatin | Q47906424 | ||
| Studies in the complex formation of metal ions with sugars. I. The complex formation of cobalt(II), cobalt(3), copper(II) and nickel(II) with mannitol | Q69469577 | ||
| Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres | Q70216445 | ||
| P433 | issue | 1-3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hydrogel | Q898925 |
| P304 | page(s) | 135-148 | |
| P577 | publication date | 1998-12-01 | |
| P1433 | published in | Journal of Controlled Release | Q6295046 |
| P1476 | title | Growth factor release from amylopectin hydrogel based on copper coordination | |
| P478 | volume | 56 |
| Q34282333 | Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review |
| Q34083391 | Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease |
| Q34019876 | Endogenous carriers and ligands in non-immunogenic site-specific drug delivery |
| Q77760300 | Targeting of tumor necrosis factor to tumor by use of dextran and metal coordination |
| Q35136117 | Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation. |
| Q35544443 | Tissue Regeneration Based on Growth Factor Release |
Search more.